| [1] |
ACOG. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion Summary, Number 782[J]. Obstet Gynecol, 2019, 134(1): 206-210.
|
| [2] |
CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention [J]. MMWR Recomm Rep, 1996, 45(RR-7):1-24.
|
| [3] |
Schrag S, Gorwitz R, Fultz-Butts K, et al. CDC. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC [J]. MMWR Recomm Rep, 2002, 51(RR-11): 1-22.
|
| [4] |
Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) [J]. MMWR Recomm Rep, 2010, 59: 1-36.
|
| [5] |
Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal diseasein neonates. Active Bacterial Core Surveillance Team [J]. N Engl J Med, 2002, 347: 233-239.
|
| [6] |
Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onsetand late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance [J]. JAMA Pediatr, 2019, 173(3): 224-233.
|
| [7] |
Le Doare K, O′Driscoll M, Turner K, et al. GBS Intrapartum Antibiotic Investigator Group.Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review[J]. Clin Infect Dis, 2017, 65(suppl-2): S143-S151.
|
| [8] |
Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference[J]. J Matern Fetal Neonatal Med, 2015, 28(7): 766-782.
|
| [9] |
Hughes RG, Brocklehurst P, Steer PJ, et al. On behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease. Green-top Guideline No.36 [J]. BJOG, 2017, 124(12): e280-e305.
|
| [10] |
Money D, Allen VM. No. 298-The prevention of early-onset neonatal group B streptococcal disease [J]. J Obstet Gynaecol Can, 2018, 40(8): e665-e674.
|
| [11] |
Darlow BA, Voss L, Lennon DR, et al. Early-onset neonatal group B streptococcus sepsis following national risk-based prevention guidelines[J]. Aust N Z J Obstet Gynaecol, 2016, 56(1): 69-74.
|
| [12] |
Virranniemi M, Raudaskoski T, Haapsamo M, et al. The effect of screening-to-labor interval on the sensitivity of late pregnancy culture in the prediction of group B streptococcus colonization at labor: a prospective multicenter cohort study [J]. Acta Obstet Gynecol Scand, 2018, 98(4): 494-499.
|
| [13] |
Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization [J]. Obstet Gynecol, 1995, 85(3): 437-439.
|
| [14] |
Jamie WE, Edwards RK, Duff P. Vaginal-perianal compared with vaginal-rectal cultures for identification of group B streptococci[J]. Obstet Gynecol, 2004, 104(5 Pt 1): 1058-1061.
|
| [15] |
Mount H, Vincent EC, Handler L. FPIN′s Clinical Inquiries. Self-administered GBS testing in pregnant women [J]. Am Fam Physician, 2014, 90(10): 729-730.
|
| [16] |
Seto MTY, Ko JKY, Cheung KW, et al. The accuracy of self-screening of group B streptococcus in pregnant women-a randomized crossover study[J]. J Obstet Gynaecol Can, 2019, 41(6): 792-797.
|
| [17] |
Church DL, Baxter H, Lloyd T, et al. Evaluation of StrepB Select Chromogenic Medium and the Fast-Track Diagnostics Group B Streptococcus (GBS) Real-Time PCR Assay compared to routine culture for detection of GBS during antepartum screening [J]. J Clin Microbiol, 2017, 55(7): 2137-2142.
|
| [18] |
El Helali N, Habibi F, Azria E, et al. Point-of-care intrapartum group B streptococcus molecular screening: effectiveness and costs [J]. Obstet Gynecol, 2019, 133: 276-281.
|
| [19] |
Russell NJ, Seale AC, O′Sullivan C, et al.Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses [J]. Clin Infect Dis, 2017, 65(suppl_2): S152-S159.
|
| [20] |
Pérez-Moreno MO, Picó-Plana E, Grande-Armas J, et al. Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study[J]. J Med Microbiol, 2017, 66(4): 454-460.
|
| [21] |
Turrentine MA, Colicchia LC, Hirsch E, et al. Efficiency of screening for the recurrence of antenatal group B streptococcus colonization in a subsequent pregnancy: a systematic review and meta-analysis with independent patient data[J]. Am J Perinatol, 2016, 33: 510-517.
|
| [22] |
Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women [J]. J Clin Microbiol, 2017, 55: 412-422.
|
| [23] |
Ghaddar N, Alfouzan W, Anastasiadis E, et al. Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait [J]. J Med Microbiol, 2014, 63(Pt 10): 1395-1399.
|
| [24] |
Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease [J]. Obstet Gynecol, 2013, 121: 570-577.
|
| [25] |
Shenoy ES, Macy E, Rowe T, et al. Evaluation and management of penicillin allergy: a review [J]. JAMA, 2019，321(2):188-199
|
| [26] |
Desravines N, Venkatesh KK, Hopkins A, et al. Intrapartum group B streptococcus antibiotic prophylaxis in penicillin allergic pregnant women [J]. AJP Rep, 2019, 9(3): e238-e243.
|
| [27] |
Mulla ZD, Ebrahim MS, Gonzalez JL. Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database [J]. Ann Allergy Asthma Immunol, 2010, 104: 55-59.
|
| [28] |
Briody VA, Albright CM, Has P, et al. Use of cefazolin for group B streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis[J]. Obstet Gynecol, 2016, 127: 577-583.
|
| [29] |
Chiang HY, Perencevich EN, Nair R, et al. Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis [J]. Infect Control Hosp Epidemiol, 2017, 38: 203-215.
|
| [30] |
Hamel MS, Has P, Datkhaeva I, et al. The effect of intrapartum vancomycin on vaginal group B streptococcus colony counts [J]. Am J Perinatol, 2019, 36(6): 555-560.
|
| [31] |
Towers CV, Weitz B. Transplacental passage of vancomycin [J]. J Matern Fetal Neonatal Med, 2018, 31:1021-1024.
|
| [32] |
Allen VM, Yudin MH. No. 276-management of group B streptococcal bacteriuria in pregnancy [J]. J Obstet Gynaecol Can, 2018, 40: e181-186.
|
| [33] |
Perez-Moreno MO, Pico-Plana E, Grande-Armas J, et al. Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study [J]. J Med Microbiol, 2017, 66: 454-460.
|
| [34] |
ACOG. Use of prophylactic antibiotics in labor and delivery. ACOG Practice Bulletin No. 199 [J]. Obstet Gynecol, 2018, 132: e103-e119.
|
| [35] |
Alvarez JR, Williams SF, Ganesh VL, et al. Duration of antimicrobial prophylaxis for group B streptococcus in patients with preterm premature rupture of membranes who are not in labor [J]. Am J Obstet Gynecol, 2007, 197: 390.e1-390.e394.
|
| [36] |
ACOG. Prelabor rupture of membranes. ACOG Practice Bulletin No. 188 [J]. Obstet Gynecol, 2018, 131: e1-e14.
|
| [37] |
ACOG. Medically indicated late-preterm and early-term deliveries. ACOG Committee Opinion No. 764[J]. Obstet Gynecol, 2019, 133:e151-e155.
|
| [38] |
Kabiri D, Hants Y, Yarkoni TR, et al. Antepartum membrane stripping in GBS carriers, is it safe? (the STRIP-G Study) [J]. PLoS One, 2015, 10:e0145905.
|
| [39] |
ACOG. Immersion in water during labor and delivery. Committee Opinion No. 679 [J]. Obstet Gynecol, 2016, 128: e231-e236.
|
| [40] |
Adair CE, Kowalsky L, Quon H, et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study [J]. CMAJ, 2003, 169: 198-203.
|
| [41] |
Santhanam S, Arun S, Rebekah G, et al. Perinatal risk factors for neonatal early-onset group B streptococcal sepsis after initiation of risk-based maternal intrapartum antibiotic prophylaxis-a case control study [J]. J Trop Pediatr, 2018, 64: 312-316.
|
| [42] |
McMaster K, Sanchez-Ramos L, Kaunitz AM. Evaluation of a transcervical foley catheter as a source of infection: a systematic review and meta-analysis [J]. Obstet Gynecol, 2015, 126: 539-551.
|
| [43] |
Siddiqui S, Zuberi NF, Zafar A, et al. Increased risk of cervical canal infections with intracervical Foley catheter [J]. J Coll Physicians Surg Pak, 2003, 13: 146-149.
|